Childhood onset tubular aggregate myopathy associated with de novo STIM1 mutations
Journal of neurology, 2014•Springer
We investigated three unrelated patients with tubular-aggregate myopathy and slowly
progressive muscle weakness manifesting in the first years of life. All patients showed type 1
muscle fiber predominance and hypotrophy of type 2 fibers. Tubular aggregates were
abundant. In all three patients mutations were identified in the gene STIM1, and the
mutations were found to be de novo in all patients. In one of the patients the mutation was
identified by exome sequencing. Two patients harbored the previously described mutation c …
progressive muscle weakness manifesting in the first years of life. All patients showed type 1
muscle fiber predominance and hypotrophy of type 2 fibers. Tubular aggregates were
abundant. In all three patients mutations were identified in the gene STIM1, and the
mutations were found to be de novo in all patients. In one of the patients the mutation was
identified by exome sequencing. Two patients harbored the previously described mutation c …
Abstract
We investigated three unrelated patients with tubular-aggregate myopathy and slowly progressive muscle weakness manifesting in the first years of life. All patients showed type 1 muscle fiber predominance and hypotrophy of type 2 fibers. Tubular aggregates were abundant. In all three patients mutations were identified in the gene STIM1, and the mutations were found to be de novo in all patients. In one of the patients the mutation was identified by exome sequencing. Two patients harbored the previously described mutation c.326A>G p.(His109Arg), while the third patient had a novel mutation c.343A>T p.(Ile115Phe). Taking our series together with previously published cases, the c.326A>G p.(His109Arg) seems to be a hotspot mutation that is characteristically related to early onset muscle weakness.
Springer